4:10 PM ET
8-K
Leadership Change
Vertex Pharmaceuticals Leadership Change
Vertex Pharmaceuticals appointed Daniel Brennan to its Board of Directors, effective October 20, 2026, increasing the board size to eleven members. Mr. Brennan, the former CFO of Boston Scientific, will also serve on the Audit and Finance Committee and received an initial $400,000 restricted stock unit award.
- Counterparty
- Daniel Brennan